-transparent.png){kind=logo}
A double-blind controlled study was performed to evaluate the effectiveness of clotrimazole in the treatment of oral candidiasis in patients with neoplastic disease. Six of seven patients who received clotrimazole had resolution of symptoms and signs of oral candidiasis. In five of six patients who received placebo, clinical progression of signs and symptoms occurred, esophagitis developed, and amphotericin B therapy had to be given. No toxicity was observed that could be attributed to clotrimazole. The results were statistically significant (p = 0.025 by Fisher's exact test). Clotrimazole is effective therapy for oral candidiasis in patients with neoplastic disease, and may prevent the development of esophagitis.
L B Shechtman, and
L Funaro, and
T Robin, and
E J Bottone, and
J Cuttner
November 1981,
The American journal of medicine,
L B Shechtman, and
L Funaro, and
T Robin, and
E J Bottone, and
J Cuttner
February 1984,
Archives of internal medicine,
L B Shechtman, and
L Funaro, and
T Robin, and
E J Bottone, and
J Cuttner
April 1987,
The American journal of medicine,
L B Shechtman, and
L Funaro, and
T Robin, and
E J Bottone, and
J Cuttner
July 1974,
Postgraduate medical journal,
L B Shechtman, and
L Funaro, and
T Robin, and
E J Bottone, and
J Cuttner
March 1979,
Archives of dermatology,
L B Shechtman, and
L Funaro, and
T Robin, and
E J Bottone, and
J Cuttner
November 1988,
The Indian journal of medical research,
L B Shechtman, and
L Funaro, and
T Robin, and
E J Bottone, and
J Cuttner
January 2022,
Journal of oral and maxillofacial pathology : JOMFP,
L B Shechtman, and
L Funaro, and
T Robin, and
E J Bottone, and
J Cuttner
November 1978,
The New England journal of medicine,
L B Shechtman, and
L Funaro, and
T Robin, and
E J Bottone, and
J Cuttner
November 1990,
Antimicrobial agents and chemotherapy,
L B Shechtman, and
L Funaro, and
T Robin, and
E J Bottone, and
J Cuttner
January 1997,
Clinical therapeutics,
